Status
Conditions
About
The aim of this study is to determine the expression of STIM1 in the plasma membrane of lymphocytes from patients suffering from different autoimmune diseases in order to identify new pathologies of interest presenting an over-expression of STIM1PM.
This would allow to initiate, following this study, research and development programs on the use of anti-STIM1 antibodies in these identified autoimmune diseases of interest.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
670 participants in 18 patient groups
Loading...
Central trial contact
Divi Cornec
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal